JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB187692

Anti-SLC1A5/ASCT2 antibody

4

(1 Review)

|

(12 Publications)

Rabbit Polyclonal SLC1A5/ASCT2 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 12 publications. Immunogen corresponding to Synthetic Peptide within Human SLC1A5 aa 450-500.

View Alternative Names

ASCT2, M7V1, RDR, RDRC, SLC1A5, Neutral amino acid transporter B(0), ATB(0), Baboon M7 virus receptor, RD114/simian type D retrovirus receptor, Sodium-dependent neutral amino acid transporter type 2, Solute carrier family 1 member 5

2 Images
Western blot - Anti-SLC1A5/ASCT2 antibody (AB187692)
  • WB

Supplier Data

Western blot - Anti-SLC1A5/ASCT2 antibody (AB187692)

All lanes:

Western blot - Anti-SLC1A5/ASCT2 antibody (ab187692) at 0.1 µg/mL

Lane 1:

HeLa whole cell lysate at 50 µg

Lane 2:

293T whole cell lysate at 50 µg

Lane 3:

Jurkat whole cell lysate at 50 µg

Predicted band size: 56 kDa

true

Exposure time: 3min

Immunoprecipitation - Anti-SLC1A5/ASCT2 antibody (AB187692)
  • IP

Supplier Data

Immunoprecipitation - Anti-SLC1A5/ASCT2 antibody (AB187692)

Detection of SLC1A5/ASCT2 in Immunoprecipitates of 293T whole cell lysate (1 mg for IP, 20% of IP loaded) using ab187692 at 6 μg/mg lysate for IP and at 1 μg/ml for subsequent Western blot detection. Lane 2 represents control IgG IP. Detection : Chemiluminescence with an exposure time of 30 seconds.

All lanes:

Immunoprecipitation - Anti-SLC1A5/ASCT2 antibody (ab187692)

Predicted band size: 56 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, WB

applications

Immunogen

Synthetic Peptide within Human SLC1A5 aa 450-500. The exact immunogen used to generate this antibody is proprietary information.

Q15758

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "2-10 µg/mg of lysate", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000 - 1/10000", "WB-species-notes": "<p></p>" }, "Chimpanzee": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Orangutan": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab187692 was affinity purified using an epitope specific to SLC1A5/ASCT2 immobilized on solid support.
Storage buffer
pH: 7 - 8 Preservative: 0.09% Sodium azide Constituents: 99% Tris citrate/phosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The SLC1A5 protein also known as ASCT2 is a sodium-dependent neutral amino acid transporter with a molecular mass of approximately 56 kDa. It plays an important role in the transport of amino acids such as glutamine across the plasma membrane. This transporter is widely expressed in multiple tissues including the liver brain and kidneys. ASCT2 is integral in maintaining amino acid balance within cells facilitating nutrient uptake essential for cellular metabolism and function.
Biological function summary

The SLC1A5 protein contributes to cellular processes by facilitating the uptake of neutral amino acids. ASCT2 operates as a part of a complex of transporters that ensure the supply of critical nutrients within cells impacting metabolic processes like protein synthesis and cell growth. Its function supports the dynamic needs of rapidly growing tissues and is especially active in conditions demanding high amino acid turnover.

Pathways

The activity of SLC1A5/ASCT2 is important in amino acid transport pathways particularly influencing the mTOR signaling which plays a significant role in cell growth and metabolic regulation. SLC1A5/ASCT2 interaction with proteins like LAT1 strengthens its involvement in these pathways. These interactions outline a network of nutrient sensing and metabolic control important for cellular proliferation and homeostasis.

SLC1A5/ASCT2 shows a significant connection to cancer as many cancer cells exploit its role in glutamine transport to fuel their rapid growth and survival. Additionally its involvement is noted in metabolic disorders where dysregulated amino acid transport can lead to imbalances in cellular metabolism. SLC1A5/ASCT2 has potential interactions with proteins like glutaminase which are often upregulated in oncogenic pathways highlighting its importance as a target for therapeutic interventions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Sodium-coupled antiporter of neutral amino acids. In a tri-substrate transport cycle, exchanges neutral amino acids between the extracellular and intracellular compartments, coupled to the inward cotransport of at least one sodium ion (PubMed : 17094966, PubMed : 23756778, PubMed : 26492990, PubMed : 29872227, PubMed : 34741534, PubMed : 8702519). The preferred substrate is the essential amino acid L-glutamine, a precursor for biosynthesis of proteins, nucleotides and amine sugars as well as an alternative fuel for mitochondrial oxidative phosphorylation. Exchanges L-glutamine with other neutral amino acids such as L-serine, L-threonine and L-asparagine in a bidirectional way. Provides L-glutamine to proliferating stem and activated cells driving the metabolic switch toward cell differentiation (PubMed : 23756778, PubMed : 24953180). The transport cycle is usually pH-independent, with the exception of L-glutamate. Transports extracellular L-glutamate coupled to the cotransport of one proton and one sodium ion in exchange for intracellular L-glutamine counter-ion. May provide for L-glutamate uptake in glial cells regulating glutamine/glutamate cycle in the nervous system (PubMed : 32733894). Can transport D-amino acids. Mediates D-serine release from the retinal glia potentially affecting NMDA receptor function in retinal neurons (PubMed : 17094966). Displays sodium- and amino acid-dependent but uncoupled channel-like anion conductance with a preference SCN(-) >> NO3(-) > I(-) > Cl(-) (By similarity). Through binding of the fusogenic protein syncytin-1/ERVW-1 may mediate trophoblasts syncytialization, the spontaneous fusion of their plasma membranes, an essential process in placental development (PubMed : 10708449, PubMed : 23492904).. (Microbial infection) Acts as a cell surface receptor for Feline endogenous virus RD114.. (Microbial infection) Acts as a cell surface receptor for Baboon M7 endogenous virus.. (Microbial infection) Acts as a cell surface receptor for type D simian retroviruses.
See full target information SLC1A5

Publications (12)

Recent publications for all applications. Explore the full list and refine your search

Journal of cellular and molecular medicine 28:e70245 PubMed39648156

2024

KLF7 Promotes Hepatocellular Carcinoma Progression Through Regulating SLC1A5-Mediated Tryptophan Metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Bao Chai,Anhong Zhang,Yang Liu,Xi Zhang,Pengzhou Kong,Zhuowei Zhang,Yarong Guo

Cancers 16: PubMed39272886

2024

ASCT2 Regulates Fatty Acid Metabolism to Trigger Glutamine Addiction in Basal-like Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jia Wang,Qian Zhang,Huaizi Fu,Yi Han,Xue Li,Qianlin Zou,Shengtao Yuan,Li Sun

Drug design, development and therapy 18:3157-3173 PubMed39071813

2024

Co-Expression Network Analysis and Molecular Docking Demonstrate That Diosgenin Inhibits Gastric Cancer Progression via SLC1A5/mTORC1 Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ning Cui,Feng Ding

Cancer research communications 4:1625-1642 PubMed38867360

2024

Claudin-4 Modulates Autophagy via SLC1A5/LAT1 as a Mechanism to Regulate Micronuclei.

Applications

Unspecified application

Species

Unspecified reactive species

Fabian R Villagomez,Julie Lang,Fredrick J Rosario,Daniel Nunez-Avellaneda,Patricia Webb,Margaret Neville,Elizabeth R Woodruff,Benjamin G Bitler

Journal of translational medicine 22:543 PubMed38844930

2024

Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Guixiong Zhang,Yitai Xiao,Jizhou Tan,Hang Liu,Wenzhe Fan,Jiaping Li

Experimental and therapeutic medicine 26:574 PubMed38023359

2023

Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaobo Wang,Lihua Yuan,Bo Lu,Dongjun Lin,Xiaojun Xu

Redox biology 63:102732 PubMed37150151

2023

Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation.

Applications

Unspecified application

Species

Unspecified reactive species

Youzi Kong,Mengting Wu,Xiaoyu Wan,Min Sun,Yankun Zhang,Zhuanchang Wu,Chunyang Li,Xiaohong Liang,Lifen Gao,Chunhong Ma,Xuetian Yue

Cellular & molecular biology letters 27:107 PubMed36474192

2022

MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30.

Applications

Unspecified application

Species

Unspecified reactive species

Xinyu Zhang,Yong Han,Shuli Liu,Bing Guo,Shengming Xu,Yue He,Liu Liu

Journal of clinical laboratory analysis 36:e24733 PubMed36371782

2022

Knockdown of hsa_circ_0043691 restrains the progression of gastric cancer by decoying miR-1294 to target pre-leukemia transcription factor 3.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Wu,Pan Gong,Zhiyong Jiang

The Kaohsiung journal of medical sciences 37:1027-1037 PubMed34405943

2021

Silencing of circ_0000517 suppresses proliferation, glycolysis, and glutamine decomposition of non-small cell lung cancer by modulating miR-330-5p/YY1 signal pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zhong-Xing Bing,Jia-Qi Zhang,Gui-Ge Wang,Yan-Qing Wang,Tian-Ge Wang,Dan-Qing Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com